For instance, concentrated regions of aberrant VCAM-1 expression, either on inflamed endothelia or on tumour surfaces, could potentially detect IBD-associated inflammatory conditions or sites of CRC metastasis when screening for colorectal disease. This evidence concerns the gene VCAM1 and inflammatory bowel disease.